For melanoma, these methods include caliper measurements, measurements of a known biomarker, such as S100B or MIA, or immunohistochemical examination of treated tumors with H&E straining or antibodies directed against Ki67 and/or apoptosis markers. The gene discussed is S100B; the disease is melanoma.